Edwards Lifesciences
EV1000 Clinical Platform
EV1000 Clinical Platform and OM2 Cable Discontinuation Notice March 2022
Discontinuation Notice
2 Pages
Preview
Page 1
March 9, 2022 Subject: Discontinuation of the EV1000 clinical platform and OM2 cable, effective December 31, 2022
Dear valued customer, At Edwards Lifesciences, we strive to be your partner in improving the quality of patient care. In alignment with this mission, this letter is to inform you that we will be discontinuing service and support of the EV1000 clinical platform due to decreasing availability of electronic components. You may continue to use the EV1000 system throughout its lifespan. EV1000 monitors covered under active service agreements will continue to receive service and support through the terms of the existing agreement, but no renewals will be offered past the end of service date. Sales of the EV1000 clinical platform will be discontinued effective immediately. For customers that do not have an existing service agreement, product support for the EV1000 will be available until December 31, 2022. Product name Model Number Figure
EV1000 clinical latform EV1 000A EV1 000CS II
In addition, the OM2 oximetry optical module will be discontinued effective December 31, 2022. Product name Model Number Figure
Oximetry optical module OM2
Edwards Llfesclences LLC One Edwards Way· Irvine, CA USA· 92614 Phone: 949 250.2500 · Fax: 949.250.2525 · www.edwards com
Availability of HemoSphere advanced monitoring platform
_-
-
•
To assist you in this transition, we are pleased to announce the availability of the HemoSphere advanced monitoring platform. The HemoSphere advanced monitoring platform provides.a comprehensive view of hemodynamics and tissue oximetry, enabling proactive decision support across care settings and diverse patient profiles. The only modular hemodynamic monitoring platform to offer full-range cuff, sensor and catheter compatibility and first-of-its-kind hypotension predictive decision support software 1, HemoSphere advanced monitoring platform enables proactive, individualized patient management and is available with the following technologies: • Acumen IQ sensor, Flo Trac sensor • Acumen !Q cuff, ClearSight finger cuff • ForeSight tissue oximetry sensor • PediaSat oximetry catheter • Swan-Ganz pulmonary artery catheter
Jf you would like to learn more about pricing and purchasing options available to you, including incentives available to upgrade to the HemoSphere advanced monitoring platform, please contact us at
1-800-822-9837 and ask to speak with your capital care representative. Edwards is committed to providing your institution, clinicians, and staff with the highest levels of customer service and support to ensure seamless product implementation and ongoing use. Thank you for choosing Edwards Lifesciences to meet your patient monitoring needs.
Sincerely, Jeremy Queenin Product Manager, US Marketing
CAUTION: Federal (United States} law restricts this device to sale by or on the order of a physician. See instructions for use for full prescribing Information, including indications, contraindications, warnings, precautions and adverse events. Edwards, Edwards lifesciences, the stylized E logo, Acumen, Acumen IQ, ClearSighl, EV1000, FloTrac, ForeSight, HemoSphere, PediaSal, Swan, and Swan-Ganz are trademarks of Edwards Lifesciences Corporation or its affiliates. All other trademarks are the property of their respective owners. PP--US-6511 v2 0 1Acurnen Hypotension Prediction Index software is unlocked with the Acumen 10 sensor in minimally-invasive mode
Edwards llfosclences lLC One Edwards Way· lr.,ne, CA USA· 92614 Phona. 949 25Q 25flO. Fax 9~9 2so 2525 · www Mwards com